A B S T R A C T Ascorbic acid is a required cofactor in the conversion of dopamine to norepinephrine in vitro, and the deficiency of this vitamin in guinea pigs is associated with degeneration of autonomic ganglion cells and with cardiac supersensitivity to norepinephrine. Because of these findings, we tested the hypothesis that ascorbic acid deficiency in man alters autonomic cardiovascular reflexes and vasomotor responses to adrenergic stimuli. We studied five normal volunteers who had been deprived of ascorbic acid for a period of 3 months; they had developed symptoms and signs of scurvy and their plasma levels of ascorbic acid averaged 0.178 +SE 0.07 mg/100 ml. We repeated the studies after giving the subjects vitamin C for a period of 4 months; they had become asymptomatic and their plasma ascorbic acid had increased to an average of 1.68 ±0.151 mg/100 ml.
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Blood flow to the left forearm (plethysmograph), arterial and central venous pressures, and heart rate were measured before and after exposure of the lower half of the body to subatmospheric levels of pressure and before and after intravenous and intra-arterial (left brachial artery) infusions of norepinephrine and tyramine.
Average values of blood flow (7.9 ±1.4 ml/min per 100 ml), arterial pressure (91.2 ±4.6 mm Hg), heart rate (68 ±4.4 beats/min), central venous pressure (6.1 ±1.1 mm Hg), and plasma catecholamines (0.68 ±0.20 /Ag/liter) obtained during ascorbic acid deficiency were not altered significantly after correction of the deficiency. Vasoconstrictor responses to intra-arterial norepinephrine and tyramine were augmented after vitamin repletion. During ascorbic acid deficiency, four subjects had This work was presented at the 41st Annual Meeting of the Central Society for Clinical Research, Chicago, 1 November 1968. A preliminary report has appeared in abstract form (1) .
INTRODUCTION
Several experimental observations indicate that ascorbic acid deficiency may be associated with abnormal cardiovascular responses. In 1947 Lee and Lee (2) demonstrated in the mesenteric vascular bed of scorbutic guinea pigs decreased reactivity of vessels less than 100 is to topically applied epinephrine. Thoa and Booker (3) reported in 1963 that increases in arterial pressure and in myocardial contractile force in response to norepinephrine were augmented in scorbutic guinea pigs and more recently Thoa, Wurtman, and Axelrod (4) proposed that this supersensitivity to norepinephrine may be related to decreased binding and inactivation of circulating norepinephrine by the heart. On the other hand, observations on atria isolated from scorbutic pigs failed to show supersensitivity to norepinephrine (5) . that ascorbic acid is necessary for the integrity of these cells.
The foregoing considerations led us to test the hypothesis that ascborbic acid deficiency in man alters cardiovascular reflexes and vasomotor responses to adrenergic stimuli.
METHODS
After approval of appropriate committees of the College of Medicine and of the Board of Supervisors of the State Prison of Fort Madison, Iowa, five healthy prisoners who volunteered for the study were admitted to the metabolic ward where intense medical and nursing supervision were provided. The subjects' diet consisted of a liquid formula which did not contain vitamin C (Table I) and their caloric intake was adjusted so that each subject maintained constant weight throughout the period of depletion. At the end of approximately 90 days, plasma levels of ascorbic acid had decreased markedly and the men had clinical manifestations of scurvy (9) (Table II) . This period of depletion will reduce the total body pool of ascorbic acid to less than 20% of normal (10) . Repletion was then begun by allowing the subjects to eat a solid diet containing 2.5 mg of ascorbic acid/day and by supplementing the diet with vitamin C in different amounts for each one of the five subjects as shown in Fig. 1 . The first study was carried out during the first week of repletion and a second study was carried out approximately 4 months later (Fig. 1) .
The subjects were lying lightly clothed and comfortably supine on a couch. H20 (1000-1500 ml) * 3000 Calories: 15% Protein, 40% Fat, and 45% Carbohydrate. This liquid formula was given through a nasogastric tube. Additional details concerning the composition of the formula with respect to minerals and vitamins have been published (9) . Responses to Lower Body Negative Entries represent blood flow to the forearm (FBF), mean arterial blood pressure (BP), calculated vascular resistance in the forearm (Res.), and heart rate (HR). Resistance was estimated from the quotient * The average values were significantly different from control observations by paired t test analyses (P < 0.05). Average differences between session I and II were not statistically significant. Immediately after LBNP there was a vasodilator response in the forearm which was transient (Fig. 2) ; all values returned to control levels within 1-1 2 min.
was placed around the arm proximal to the plethysmograph for venous occlusion. Changes in forearm volume produced by sudden inflation of the venous occlusion cuff were used to measure the rate of blood flow to the forearm (12) ( Fig. 2) .
A suction box was applied around the lower half of the body to the level of the anterior-superior iliac spine and a plastic sheet enveloped it to provide the seal necessary for maintaining subatmospheric levels of pressure within the box. The box was connected to the hose of a commercial vacuum cleaner and the degree of suction was regulated by adjusting the opening of a slot on the side of the connecting hose. The lower half of the body could thus be exposed to subatmospheric levels of pressure at -20, -40, or -60 mm Hg for any desired period of time.
After the subjects had achieved a stable resting state, blood flow to the forearm, arterial pressure, central venous pressure, and heart rate were measured in response to lower body negative pressure (LBNP) and to intra-arterial and intravenous infusions of norepinephrine and tyramine. After obtaining control values, suction was applied to create a negative pressure of 20 mm Hg for 3 min; the level of suction was then increased to achieve a pressure of -40 mm Hg for a period of 3 min and -60 mm Hg for 3 additional min before discontinuing suction. Arterial blood samples for measurements of blood gases, pH, hematocrit, and blood levels of catecholamines were obtained before LBNP and during the last 3 min of LBNP. Responses were also measured during the intra-arterial infusion of two doses of norepinephrine (0.002 and 0.004 ,ug/kg per min), the intra-arterial infusion of two doses of tyramine (0.3 and 0.6 ,ug/kg per min), the intravenous infusion of two or three doses of norepinephrine (0.0375, 0.075, and 0.150 jug/kg per min), and finally the intravenous infusion of two doses of tyramine (12.5 and 25 leg/kg per min). The graded doses of each drug were infused consecutively each for 3 min.
Resting periods of 15 min were allowed between each set of infusions. The doses of norepinephrine are given in terms of the base of l-norepinephrine bitartrate which was diluted in 5%o glucose in water and infused at rates of 0.6 and 1.2 ml/min. RESULTS Each patient had more than one manifestation of ascorbic acid deficiency at the time of the first study and the plasma levels of ascorbic acid were markedly reduced (Table II) . At the time of the second study, the clinical manifestations of scurvy had disappeared and plasma levels of ascorbic acid had increased.
Resting values of arterial blood pressure, heart rate, central venous pressure, and blood flow to the forearm were similar in the first and second sessions (Tables III,   V , and Figs. 3 and 4) .
Effect of lower body negative pressure. During session I, LBNP caused a sensation of fainting in two of the five subjects whose mean blood pressures fell by 35 mm Hg (R) and 48 mm Hg (Mc). The other three subjects had little or no reduction in arterial pressure. During the second session, the largest reduction in arterial pressure was 19 mm Hg (S) ( Table III) . Vascular resistance of the forearm increased during LBNP but the average resistance attained over the 9 min period of suction was lower in three of the five subjects (S, Mc, and H) in the first session as compared to the second session.
The tachycardia and the reductions in central venous pressure were similar in the two sessions.
The values of arterial Po0, Pco2, pH, hematocrit, and plasma catecholamine concentrations are in Table  IV . There were no consistent differences in these values during the two sessions, both before and during LBNP. A slight reduction in Pco2 took place during LBNP in both sessions.
Responses to intra-arterial infusions of norepinephrine and tyramine. The doses used were insufficient to cause any change in systemic arterial blood pressure or heart rate but reductions in blood flow to the forearm were apparent. The responses to both norepinephrine and tyramine were less in session I than in session II (Tables V and VI) .
Responses to intravenous infusions of norepinephrine and tyramine. Norepinephrine caused a rise in arterial pressure, a decrease in forearm blood flow, an increase in forearm vascular resistance, and bradycardia in each of the five subjects during session I (Fig. 3) . After repletion of ascorbic acid, responses tested in only four of the five subjects were not altered consistently.
During session I tyramine caused a rise in arterial pressure with some increase in blood flow to the forearm, a small increase in forearm vascular resistance, and a decrease in heart rate. These responses were not altered consistently in session II (Fig. 4) .
DISCUSSION
We are reporting in this paper one of several studies which were carried out on five scorbutic men. One of the studies included an evaluation of the tolerance of these men to a cold environment for several hours. They had been deprived of ascorbic acid for a period of 84-97 days and had just started their repletion regimen when one of us (J. H.) observed that they had an unusual degree of edema of the feet and cyanosis when exposed to the cold. This observation led us to postulate that there may be some alteration in vascular reactivity in CENTRAL VENOUS PRESSURE (mmHo)-1_&. _ I, 11 ,., XVe reasoned that if the biochemical and pathophysiological defects which were observed in vitro and in vivo in the guinea pigs occurred also in man we should be able to identify a defect in cardiovascular reflexes in the scorbutic subjects. Such a defect would not necessarily explain the edema and cyanosis that were observed in the cold; but because of its importance and the scarcity of studies on vascular responsiveness in human scurvy. we decided to evaluate the integrity of adrenergic responses in these five subjects who had already become scorbutic. This was done by testing the effects of pooling of blood in the lower extremities and of intra-arterial and intravenous norepinephrine and tyramine. Exposure of the lower half of the body to subatmospheric pressures causes pooling of blood in the lower parts, decreases central venous pressure, and triggers reflex tachycardia and reflex vasoconstriction in the forearm. The responses are similar to those seen during upright tilt (13); they reflect to a major degree the integrity of the autonomic nervous system and they are abolished in autonomic neuropathy (14, 15) . When endogenous catecholamines are depleted, the cardiovascular effects of norepinephrine may be augmented (16) but those of tyramine are reduced since tyramine acts through the release of endogenous catecholamines (17) (18) (19) . Thus, the relative responses to norepinephrine and tyramine during ascorbic acid deficiency and after its correction provide an indirect index of endogenous catecholamines in these two states.
The results indicate that during the first session when plasma levels of ascorbic acid were negligible and the clinical manifestations of scurvy were evident tachycardia resulted from pooling of blood in the lower extremities and bradycardia was triggered by elevation of arterial pressure with intravenous norepinephrine and tyramine. Similar responses were seen 4 months later during the second session after full repletion of the vitamin and disappearance of all signs and symptoms of the deficiency suggesting that autonomic innervation of the heart was not affected by the vitamin deficiency.
The findings with intra-arterial norepinephrine and tyramine would not support the concept that there is significant depletion of endogenous catecholamines during experimental scurvy in man. Had there been depletion, the vasoconstrictor response to tyramine would have been reduced and the response to norepinephrine would have been augmented, and this differential effect of the two sympathomimetic amines would have been reversed after repletion of ascorbic acid. The results indicate, however, that the responses to both norepinephrine and tyramine were reduced during ascorbic acid deficiency. Thus, although the vasoconstrictor effect of intraarterial tyramine was reduced in session I as compared to session II, this reduction does not indicate depletion of catecholamines since the vasoconstrictor effect of intra-arterial norepinephrine, which acts directly on adrenergic alpha receptors, was also reduced in session I. The decreased responsiveness should therefore be attributed to either a nonspecific reduction in contractility of vascular smooth muscle in scurvy or a diminution in responsiveness to adrenergic stimuli. In their studies on mesenteric vessels of scorbutic guinea pigs, Lee and Lee reported decreased responsiveness of venules and arterioles less than 100 AL in topical applications of epinephrine; the responsiveness of larger vessels was not altered (2) .
The levels of arterial pressure and of forearm vascular resistance which were attained during LBNP also suggest that the responsiveness of resistance vessels of the forearm to LBNP was less in session I than in session II in four of the five subjects. Two subjects (R and Mc) had marked reductions in arterial blood pressure accompanied by a sensation of dizziness and fainting during LBNP in session I. These effects were not seen after repletion of ascorbic acid; and although the levels of vascular resistance of the forearm were not consistently lower during LBNP in session I in these two subjects, the more pronounced hypotension would indicate that vascular tone was less during LBNP in session I than in session II. Two other subjects (S and H had lower levels of vascular resistance associated with slightly lower levels of pressure during LBNP in session I than in session II suggesting also that vascular tone was less during LBNP in the first session.
The constrictor effects of intravenous norepinephrine and tyramine on resistance vessels of the forearm were not augmented consistently after repletion of ascorbic acid as were the responses to the intra-arterial infusions. It should be mentioned in this connection that responses to intravenous infusions include in addition to the direct action of the drugs on blood vessels a possible central action or myogenic and neurogenic reflex effects which may either mask, modify, or override any direct effects. Deprivation from ascorbic acid was maintained for a period of 3 months. It might be argued that this period was insufficient to induce scurvy in view of previous studies in which the deficiency had to be maintained for more than 4 months before the appearance of symptoms and signs of scurvy (20) (21) (22) (23) . In this as in previous studies by our group (9, 10, 24) , the 3 month period was sufficient to decrease the total body pool of ascorbic acid to less than 20%, to decrease the plasma levels to less than 0.1 mg/100 ml in most subjects and to cause definite clinical manifestations of scurvy. Rigid dietary restriction may have been a factor in our ability to induce scurvy in a shorter period of time than was possible in earlier studies.
In the present experiments, session I was held 3-10 days after the beginning of repletion of ascorbic acid rather than at the end of the depletion phase. Press, Ames, edition 5). The significance of the variation ascribed to "Sessions" indicates that responses to the sympathomimetic amines were different in the two sessions and the significance of the variation of "Doses" indicates that there was a dose-related effect. The lack of significance of the variation ascribed to Sessions X Doses interactions indicates that the dose-response curves in the two sessions were parallel. $ Indicates P < 0.05.
fore, a deficiency of ascorbic acid which is important for that step might not be expected to result in significant reductions in the synthesis of endogenous norepinephrine. In guinea pigs, scurvy may be induced within 2-3 wk and the metabolic pathways of ascorbic acid are different in pigs and in man so that the pathophysiology of scurvy may be different in the two species.
